These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6589034)

  • 1. Chromosome changes and splenectomy in Ph1-positive CML. II. Prognostic aspects in the blastic phase.
    Sadamori N; Sandberg AA
    Cancer Genet Cytogenet; 1984 Aug; 12(4):303-8. PubMed ID: 6589034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome changes and splenectomy in Ph1-positive chronic myeloid leukemia. I. Predictive parameters in the blastic phase.
    Sadamori N; Sandberg AA
    Cancer; 1984 Dec; 54(11):2456-9. PubMed ID: 6594187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic and prognostic value of initial chromosomal findings at the blastic phase of Ph1-positive chronic myeloid leukemia.
    Sadamori N; Gomez GA; Sandberg AA
    Blood; 1983 May; 61(5):935-9. PubMed ID: 6572536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomes and causation of human cancer and leukemia. IL. Therapeutic and prognostic value of chromosomal findings during acute phase in Ph1-positive chronic myeloid leukemia.
    Sadamori N; Gomez GA; Sandberg AA
    Hematol Oncol; 1983; 1(1):77-83. PubMed ID: 6588019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome changes and splenectomy in Ph-positive CML. III. Predictive parameters in the chronic phase.
    Sadamori N; Sandberg AA
    Cancer Genet Cytogenet; 1985 Jan; 14(3-4):227-34. PubMed ID: 3855366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic and prognostic value of chromosomal AP classification at the blastic phase of Ph-positive chronic myeloid leukemia: comparison of data from Nagasaki University, Japan and Roswell Park Memorial Institute, U.S.A.
    Sadamori N; Yao E; Mine M; Tokunaga S; Matsunaga M; Nakamura H; Sasagawa I; Itoyama T; Kawachi T; Sandberg AA
    Leuk Lymphoma; 1991; 5(2-3):187-92. PubMed ID: 21269080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomes and causation of human cancer and leukemia. XXIX. Further studies on karyotypic progression in CML.
    Sonta S; Sandberg AA
    Cancer; 1978 Jan; 41(1):153-63. PubMed ID: 272225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of abnormal clone of leukaemic cells by splenectomy.
    Gomez G; Hossfeld DK; Sokal JE
    Br Med J; 1975 May; 2(5968):421-3. PubMed ID: 1055011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spleen size and chromosome analysis as prognostic factors in chronic myelogenous leukemia.
    Collins RK; Jackson JF; Morrison FS; Meydrech EF
    South Med J; 1979 Jun; 72(6):642-4, 651. PubMed ID: 287200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Karyotypic evolution in Ph-positive chronic myeloid leukemia in relation to management and disease progression.
    Swolin B; Weinfeld A; Westin J; Waldenström J; Magnusson B
    Cancer Genet Cytogenet; 1985 Sep; 18(1):65-79. PubMed ID: 3861236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Philadelphia chromosome-positive chronic myelocytic leukemia in children. Survival and prognostic factors.
    Castro-Malaspina H; Schaison G; Briere J; Passe S; Briere J; Pasquier A; Tanzer J; Jacquillat C; Bernard J
    Cancer; 1983 Aug; 52(4):721-7. PubMed ID: 6574807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome abnormalities in chronic myeloid leukemia in children.
    Puchkova GP; Prigogina EL; Fleischmann EW; Drosdova TS; Mayakova SA; Peterson IS
    Hum Genet; 1983; 64(3):257-62. PubMed ID: 6576982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal evolution with isodicentric Ph1 chromosome in Ph1-positive CML: karyotypic conversion after bone marrow transplantation.
    Becher R; Ohl S; Schaefer UW; Wendehorst E; Quiskamp F; Mahmoud HK; Schüning F; Schmidt CG
    Blut; 1984 Apr; 48(4):247-50. PubMed ID: 6370340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patho-anatomical features of so-called Ph1- chronic myeloid leukemia.
    Schwarze EW; Schwalbe P; Klein UE
    Virchows Arch A Pathol Anat Histol; 1975 Jul; 367(2):137-48. PubMed ID: 808893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The L-5 protocol: intensive treatment for patients with chronic myeloid leukemia.
    Gee TS; Cunningham I; Dowling MD; Chaghanti R; Clarkson BD
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):289-93. PubMed ID: 282899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth pattern and SCE incidence in Ph1-positive cells of CML.
    Abe S; Kakati S; Sandberg AA
    Cytobios; 1980; 28(111-112):137-49. PubMed ID: 6938334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sister chromatid exchange in Philadelphia chromosome (Ph1)-positive leukemia.
    Kakati S; Abe S; Sandberg AA
    Cancer Res; 1978 Sep; 38(9):2918-21. PubMed ID: 277286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomes and causation of human cancer and leukemia: XXXIX. Usual and unusual findings in Ph1-positive CML.
    Kohno SI; Sandberg AA
    Cancer; 1980 Nov; 46(10):2227-37. PubMed ID: 6932994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of chromosomal findings in Ph1-positive chronic myelocytic leukemia.
    Sakurai M; Hayata I; Sandberg AA
    Cancer Res; 1976 Feb; 36(2 Pt 1):313-8. PubMed ID: 1063061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical findings and prognostic factors in chronic myeloid leukemias.
    Wedelin C; Björkholm M; Mellstedt H; Gahrton G; Holm G
    Acta Med Scand; 1986; 220(3):255-60. PubMed ID: 3465200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.